Which antidepressants are safe for a patient with bulimia nervosa?

Safe Antidepressants for Bulimia Nervosa

Fluoxetine at 60 mg daily is the only FDA-approved antidepressant for bulimia nervosa and should be your first-line pharmacologic choice when medication is indicated. 1

When to Prescribe Antidepressants

The American Psychiatric Association recommends starting with eating disorder-focused cognitive-behavioral therapy as first-line treatment for adults with bulimia nervosa. 1 Add fluoxetine either:

• Initially alongside psychotherapy, or
• After 6 weeks if minimal or no response to psychotherapy alone 1

This approach allows psychotherapy to work while providing pharmacologic backup when needed.

First-Line Medication: Fluoxetine

Fluoxetine 60 mg daily is the only antidepressant with FDA approval for bulimia nervosa and carries the strongest evidence base. 2

• Efficacy: Produces significantly greater reductions in both vomiting episodes (p<0.0001) and binge-eating episodes (p=0.0002) compared to placebo over 16 weeks 3
• Safety profile: Well-tolerated with minimal adverse effects and lower dropout rates than other antidepressants 4
• Tolerability advantage: Patients treated with fluoxetine actually drop out less frequently than placebo, suggesting it is a more acceptable treatment compared to tricyclic antidepressants 4
• Duration: Demonstrated safe and effective for up to 16 weeks of continuous treatment 3

Other SSRI Options

If fluoxetine is contraindicated or not tolerated, other SSRIs represent reasonable alternatives, though they lack FDA approval for bulimia nervosa. 1

• General SSRI class: Shows moderate benefit with pooled relative risk of 0.88 for remission of binge episodes (95% CI 0.83-0.93, p<0.001) 4
• Number needed to treat: Only 9 patients need treatment for 8 weeks for one additional remission 4
• Clinical improvement: 50% or more reduction in binge episodes achieved with NNT of 4 (95% CI 3-6) 4

Tricyclic Antidepressants (Use With Caution)

TCAs (imipramine, desipramine, amitriptyline) show efficacy but have a less favorable risk-benefit profile. 5

• Evidence level: Grade A evidence exists but with only moderate risk-benefit ratio 5
• Tolerability concern: Higher dropout rates due to any cause compared to placebo, unlike fluoxetine 4
• Consider only when SSRIs have failed or are contraindicated

MAOIs (Phenelzine, Isocarboxazid, Brofaromine)

MAOIs demonstrate efficacy similar to other antidepressant classes but require dietary restrictions. 4

• Use only when SSRIs and TCAs have failed
• Require strict adherence to tyramine-free diet
• Higher burden of side effects and drug interactions

CRITICAL CONTRAINDICATION: Bupropion

Never prescribe bupropion for bulimia nervosa—it is absolutely contraindicated. 6

• Seizure risk: Four out of 55 patients (7.3%) experienced grand mal seizures during treatment, a rate far higher than in non-bulimic populations 6
• This elevated seizure risk is likely related to electrolyte disturbances from purging behaviors
• Despite showing efficacy for binge reduction, the seizure risk makes it unacceptable 6

Pre-Treatment Safety Assessment

Before starting any antidepressant in bulimia nervosa, obtain: 1

• Vital signs: Temperature, resting heart rate, blood pressure, orthostatic pulse and blood pressure
• Laboratory tests: Complete blood count, comprehensive metabolic panel including electrolytes, liver enzymes, and renal function
• ECG: Required in patients with severe purging behavior, as they may be taking medications that prolong QTc intervals 1

Electrolyte abnormalities (especially hypokalemia) from purging can increase cardiac risks with certain antidepressants.

Treatment Algorithm

1. Initiate eating disorder-focused CBT 1
2. Add fluoxetine 60 mg daily either immediately or at 6 weeks if inadequate response 1
3. If fluoxetine fails or is not tolerated: Consider alternative SSRI
4. If SSRIs fail: Consider TCA with close monitoring
5. Never use bupropion regardless of treatment resistance 6

Common Pitfalls to Avoid

• Underdosing fluoxetine: The effective dose is 60 mg daily, not the typical 20 mg used for depression 1
• Ignoring purging severity: Severe purging requires ECG monitoring before starting antidepressants 1
• Prescribing bupropion: This remains contraindicated despite its antidepressant efficacy 6
• Medication monotherapy: Antidepressants work best when combined with eating disorder-focused psychotherapy 1